Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1975 of 2228 entries
View as:

Safety, Tolerability, Pharmacokinetics of Single Rising Oral Doses of BI 1181181 in Healthy Male Volunteers, Including Investigation of the Effect of Food on the Bioavailability of BI 1181181

Phase: N/A Priority: Normal
NCT ID: NCT02044406 Org: User:
Start: 01/31/14 End: 09/30/14 Due: 09/30/15

DDI Between BI Empagliflozin (10773) and Verapamil

Phase: N/A Priority: Normal
NCT ID: NCT01276301 Org: User:
Start: 01/31/11 End: - Due: -

Pharmacodynamics, Preliminary Pharmacokinetics and Tolerability of BIBB 515 BS or Pravastatin in Hyperlipemic Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02266485 Org: User:
Start: 07/31/98 End: - Due: -

A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT05934942 Org: User:
Start: 09/08/23 End: 02/08/24 Due: 02/08/25

A Study to Test Long-term Treatment With Spesolimab in Patients With Fistulising Crohn's Disease Who Took Part in Previous Trials

Phase: N/A Priority: Normal
NCT ID: NCT04362254 Org: User:
Start: 05/15/20 End: 09/23/22 Due: 09/23/23

Pramipexole ER vs. Placebo in Fibromyalgia

Phase: N/A Priority: Normal
NCT ID: NCT00689052 Org: User:
Start: 07/31/08 End: - Due: -

Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00168779 Org: User:
Start: 09/30/05 End: 07/31/06 Due: 07/31/07

A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology.

Phase: N/A Priority: Normal
NCT ID: NCT01346540 Org: User:
Start: 04/14/11 End: 01/17/17 Due: 01/17/18

Telmisartan Compared With Enalapril in Elderly Patients With Blood Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02177461 Org: User:
Start: 04/30/00 End: - Due: -

Effect of Cytochrome P 450 3A4 Inhibition by Itraconazole on the Single Oral Dose Pharmacokinetics of Cilobradine

Phase: N/A Priority: Normal
NCT ID: NCT02264041 Org: User:
Start: 01/31/04 End: - Due: -

A Study in Healthy Men to Find Out How Well Different Doses of BI 764122 Are Tolerated and Whether Food Affects the Amount of BI 764122 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT03794323 Org: User:
Start: 01/30/19 End: 08/12/19 Due: 08/12/20

Survey on Long-Term Use of BI-Sifrol® Tablets in Patients With Restless Legs Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01174459 Org: User:
Start: 08/31/10 End: 08/31/13 Due: 08/31/14

Bioequivalence of Telmisartan/g Ramipril Fixed Dose Combination Compared With the Monocomponents Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02214992 Org: User:
Start: 03/31/07 End: - Due: -

A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the Body

Phase: N/A Priority: Normal
NCT ID: NCT06772532 Org: User:
Start: 02/10/25 End: 06/10/25 Due: 06/10/26

A Study in Healthy Men to Find the Best Formulation of BI 685509 and to Test How it is Taken up in the Body

Phase: N/A Priority: Normal
NCT ID: NCT04926246 Org: User:
Start: 07/01/21 End: 02/07/22 Due: 02/07/23

Phase I Study of AbGn-168H in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01378364 Org: User:
Start: 06/30/11 End: - Due: -

Effect of BIIL 284 BS on Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02249338 Org: User:
Start: 10/31/99 End: - Due: -

Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH

Phase: N/A Priority: Normal
NCT ID: NCT03166735 Org: User:
Start: 06/06/17 End: 06/14/19 Due: 06/14/20

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT01083732 Org: User:
Start: 03/31/10 End: 02/29/16 Due: 02/28/17

Pharmacokinetics, Safety and Efficacy of BIIL 284 BS in Patients With Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT02247375 Org: User:
Start: 01/31/00 End: - Due: -

Pharmaton Upgrade in Improving Mental Performance and Decreasing Fatigue

Phase: N/A Priority: Normal
NCT ID: NCT00144235 Org: User:
Start: 03/31/05 End: 07/31/05 Due: 07/31/06

Drug-drug Interaction Trial of BI 113608 in Combination With Ketoconazole and Voriconazole in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01787032 Org: User:
Start: 01/31/13 End: 04/30/13 Due: 04/30/14

Expanded Access Study of Afatinib in Treatment-naive or Chemotherapy Pre-treated Patients With Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT01931306 Org: User:
Start: - End: - Due: -

This Study Looks at the Effects of Idarucizumab in Patients Who Take Dabigatran and Need Emergency Surgery or Are Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT03343704 Org: User:
Start: 03/26/18 End: 07/02/20 Due: 07/02/21

A Dose Response Study of Dabigatran Etexilate(BIBR 1048) in Pharmacodynamics and Safety in Patients With Non-valvular Atrial Fibrillation in Comparison to Warfarin

Phase: N/A Priority: Normal
NCT ID: NCT01136408 Org: User:
Start: 11/30/05 End: - Due: -